ALEXANDRIA, Va., July 16 -- United States Patent no. 12,359,261, issued on July 15, was assigned to Quest Diagnostics Investments LLC (Secaucus, N.J.).
"Assay for detection of pathogenic Leptospira strains" was invented by Erik P. Johnson (Carlsbad, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods and compositions for determining the presence and/or amount of pathogenic Leptospira in a test sample. In particular, substantially purified oligonucleotide primers and probes are described that can be used for qualitatively and quantitatively detecting pathogenic Leptospira nucleic acid in a test sample by amplification methods. The present invention also provides primer...